Embolx, a developer of microcatheters for targeted embolization procedures, announced the market release of its ...

If you’re suffering from osteoarthritis or chronic knee pain, Genicular Artery Embolization (GAE) might be the solution you ...

Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its ...

Key Points Penumbra topped analyst forecasts with $339.5 million in GAAP revenue and $0.86 non-GAAP EPS, driven by double-digit U.S. thrombectomy growth. Gross margin (GAAP) expanded sharply to 66.0%, ...

In the preceding three months, 7 analysts have released ratings for Penumbra PEN, presenting a wide array of perspectives ...

Shares of medical device company Penumbra (NYSE:PEN) jumped 11.8% in the afternoon session after the company reported impressive second-quarter financial results that surpassed analyst expectations ...

**media[691771]**SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ -- Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation ...

The six-month follow-up results from the pioneering trial of robotic-assisted neuroendovascular aneurysm embolization using ...

Q2 2025 Earnings Conference Call July 29, 2025 4:30 PM ETCompany ParticipantsAdam Elsesser - Co-Founder, Chairman, President ...

Here’s why a wellness platform is announcing a clinical study on supporting fibroids with Chinese medicine to address a major gap in women’s health.